SEC Company Response from MICRUS ENDOVASCULAR CORP (CIK 0001028318) — Jun 13, 2005
MICRUS ENDOVASCULAR CORP (CIK 0001028318)
Date: June 13, 2005 · CIK: 0001028318 · Accession: 0000950134-05-011850
AI Filing Summary & Sentiment
File numbers found in text: 333-123154
Letter
June 13, 2005
VIA EDGARLINK AND FACSIMILE
Securities and Exchange Commission
Division of Corporate Finance
Mail Stop 0306
450 Fifth Street, N.W.
Washington, DC 20549
Attn:
Peggy A. Fisher, Assistant Director
Adélaja K. Heyliger
Tara Harkins
Jay Webb
Re:
Micrus Endovascular Corporation (fka Micrus Corporation)
Registration Statement on Form S-1
File No. 333-123154
Filed on March 4, 2005, as amended April 13, 2005, May 6, 2005,
May 17, 2005, May 23, 2005 and June 10, 2005
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effectiveness of the above referenced Registration Statement, to become effective at 3:00 p.m. E.D.T., June 15, 2005, or as soon as reasonably practicable thereafter.
Sincerely,
/s/ Robert A. Stern
Show Raw Text
CORRESP
1
filename1.htm
corresp
June 13, 2005
VIA EDGARLINK AND FACSIMILE
Securities and Exchange Commission
Division of Corporate Finance
Mail Stop 0306
450 Fifth Street, N.W.
Washington, DC 20549
Attn:
Peggy A. Fisher, Assistant Director
Adélaja K. Heyliger
Tara Harkins
Jay Webb
Re:
Micrus Endovascular Corporation (fka Micrus Corporation)
Registration Statement on Form S-1
File No. 333-123154
Filed on March 4, 2005, as amended April 13, 2005, May 6, 2005,
May 17, 2005, May 23,
2005 and June 10, 2005
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as
amended, we hereby request acceleration of the effectiveness of the above referenced Registration
Statement, to become effective at 3:00 p.m. E.D.T., June 15, 2005, or as soon as reasonably
practicable thereafter.
Sincerely,
/s/ Robert A. Stern
Robert A. Stern
Executive Vice President & Chief Financial Officer
cc:
Kelly N. Shiflett (The Nasdaq Stock Market)
Glen R. Van Ligten (Orrick, Herrington & Sutcliffe LLP)
Karen I. Calhoun (McDermott, Will & Emery)